Namoc, Eliseo R.
HRN: 25-90-01 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/20/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/20/2024
09/26/2024
IV
2.25
Q6h
PMBO
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes